Atlas Venture Associates IX, LLC - Q4 2021 holdings

$229 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .

 Value Shares↓ Weighting
SKLZ  SKILLZ INC$170,449,000
-24.2%
22,909,8590.0%74.40%
-0.5%
SPRO  SPERO THERAPEUTICS INC$22,045,000
-13.0%
1,376,9680.0%9.62%
+14.2%
SURF  SURFACE ONCOLOGY INC$14,079,000
-36.9%
2,945,4530.0%6.14%
-17.1%
COGT  COGENT BIOSCIENCES INC$7,866,000
+2.0%
916,8320.0%3.43%
+33.9%
SNAP  SNAP INCcl a$7,063,000
-36.3%
150,1600.0%3.08%
-16.4%
SYBX  SYNLOGIC INC$6,418,000
-20.6%
2,651,9630.0%2.80%
+4.2%
NTLA  INTELLIA THERAPEUTICS INC$1,182,000
-11.9%
10,0000.0%0.52%
+15.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-01-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings